Workflow
盈利预期修正
icon
搜索文档
TD SYNNEX (SNX) Surpasses Q3 Earnings and Revenue Estimates
ZACKS· 2025-09-25 12:16
TD SYNNEX (SNX) came out with quarterly earnings of $3.58 per share, beating the Zacks Consensus Estimate of $3.02 per share. This compares to earnings of $2.86 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +18.54%. A quarter ago, it was expected that this high-tech contractor would post earnings of $2.69 per share when it actually produced earnings of $2.99, delivering a surprise of +11.15%.Over the last four quarters, the ...
MillerKnoll (MLKN) Beats Q1 Earnings and Revenue Estimates
ZACKS· 2025-09-23 22:26
MillerKnoll (MLKN) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.35 per share. This compares to earnings of $0.36 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +28.57%. A quarter ago, it was expected that this furniture maker would post earnings of $0.35 per share when it actually produced earnings of $0.6, delivering a surprise of +71.43%.Over the last four quarters, the com ...
Strength Seen in Premier (PINC): Can Its 9.7% Jump Turn into More Strength?
ZACKS· 2025-09-23 13:46
Premier, Inc. (PINC) shares ended the last trading session 9.7% higher at $28.25. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 2.4% gain over the past four weeks.Premier witnessed a strong price rise on investors’ optimism after announcing that it has entered into a definitive agreement to be acquired by an affiliate of Patient Square Capital (“Patient Square”). Under the terms of the agreement, which has been u ...
908 Devices (MASS) Surges 7.0%: Is This an Indication of Further Gains?
ZACKS· 2025-09-22 14:00
908 Devices Inc. (MASS) shares ended the last trading session 7% higher at $7.3. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 13.3% gain over the past four weeks.908 Devices witnessed a strong price rise on investors’ optimism surrounding its robust revenue growth in Q2. Additionally, the company strengthened its financial position by completing the previously announced restructuring efforts - cutting facility s ...
Mesa Labs (MLAB) Stock Jumps 5.7%: Will It Continue to Soar?
ZACKS· 2025-09-22 11:56
股价表现 - 股价单日上涨5.7%至73.14美元 成交量显著高于平均水平 [1] - 过去四周累计涨幅为3.4% [1] 股价驱动因素 - 投资者看好公司商业成功、关键计划进展及弹性运营模式 [2] - 公司偿还2025年8月到期的1.375%可转换优先票据 本金总额达9750万美元 [2] 业绩预期 - 预计季度每股收益2.59美元 同比增长5.7% [3] - 预计季度营收6130万美元 同比增长6% [3] - 共识EPS预期在过去30天内维持不变 [4] 同业比较 - 同业公司Waters股价单日下跌1.8%至300.87美元 [4] - Waters过去一个月涨幅5.5% [4] - Waters预计季度EPS为3.22美元 同比增长9.9% [5] 行业评级 - 公司隶属Zacks医疗仪器行业 [4] - 公司Zacks评级为3级(持有) [4] - Waters公司Zacks评级同样为3级(持有) [5]
Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?
ZACKS· 2025-09-22 09:41
Aquestive Therapeutics (AQST) shares rallied 14.8% in the last trading session to close at $5.67. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 26.3% gain over the past four weeks.The surge in stock price is likely due to positive expectations from investors regarding Aquestive’s regulatory filing, which seeks FDA approval for its key product candidate, Anaphylm, to treat severe allergic reactions. Earlier ...
Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade
ZACKS· 2025-09-18 14:56
Shares of Bright Minds Biosciences Inc. (DRUG) have gained 3.9% over the past four weeks to close the last trading session at $44.68, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $81 indicates a potential upside of 81.3%.The mean estimate comprises five short-term price targets with a standard deviation of $8.34. While the lowest estimate of $72.00 indicates a 61.2% increase ...
Darden Restaurants (DRI) Misses Q1 Earnings Estimates
ZACKS· 2025-09-18 13:11
Darden Restaurants (DRI) came out with quarterly earnings of $1.97 per share, missing the Zacks Consensus Estimate of $2 per share. This compares to earnings of $1.75 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -1.50%. A quarter ago, it was expected that this owner of Olive Garden and other chain restaurants would post earnings of $2.96 per share when it actually produced earnings of $2.98, delivering a surprise of +0.68%. ...
Performance Food (PFGC) Surges 3.8%: Is This an Indication of Further Gains?
ZACKS· 2025-09-18 12:21
股价表现 - Performance Food Group股价在上一交易日上涨3.8%至108.72美元 伴随显著放量交易 [1] - 该股过去四周累计涨幅达5.5% 近期表现优于同期行业对比公司 [1][4] - 同行业公司Sprouts Farmers同期股价下跌1.7%至123.36美元 过去一个月累计下跌14.8% [4] 战略合作动向 - 公司与US Foods启动信息共享程序 探索监管考量和协同效应 [2] - 市场对潜在业务合并持乐观态度 成为推动股价上涨的重要因素 [2] 财务预期 - 季度每股收益预期维持1.16美元 与去年同期持平 [3] - 预期营收将达168.6亿美元 同比增长9.4% [3] - 过去30天内共识EPS预期上调1.6% 显示盈利修正呈积极趋势 [4] 同业对比 - Sprouts Farmers季度EPS预期较上月上调0.4%至1.16美元 [5] - 该公司预期EPS同比增幅达27.5% 目前获Zacks买入评级 [5] - Performance Food所属天然食品行业 Zacks评级为持有 [4]
Does CI&T (CINT) Have the Potential to Rally 36.83% as Wall Street Analysts Expect?
ZACKS· 2025-09-17 14:56
CI&T Inc. (CINT) closed the last trading session at $5.62, gaining 9.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $7.69 indicates a 36.8% upside potential.The mean estimate comprises eight short-term price targets with a standard deviation of $0.95. While the lowest estimate of $6.70 indicates a 19.2% increase from the current price level, the most optimistic analyst expects ...